How to buy Polynovo (PNV) shares
Learn how to easily invest in Polynovo shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
PolyNovo Limited is a medical devices business based in Australia. Polynovo shares (PNV) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Polynovo has a trailing 12-month revenue of around $29.2 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Polynovo
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Polynovo. Find the share by name or ticker symbol: PNV. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Polynovo reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Polynovo. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Polynovo stock price (ASX:PNV)Use our graph to track the performance of PNV stocks over time.
Polynovo shares at a glance
|52-week range||$1.65 - $4.08|
|50-day moving average||$1.9441|
|200-day moving average||$2.4279|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.007|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Polynovo stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Polynovo price performance over time
|1 week (2021-10-12)||8.75%|
|1 month (2021-09-20)||-2.36%|
|3 months (2021-07-20)||-13.66%|
|6 months (2021-04-20)||-39.64%|
|1 year (2020-10-19)||-25.99%|
|2 years (2019-10-18)||-22.29%|
|3 years (2018-10-19)||210.83%|
|5 years (2016-10-19)||482.81%|
|Revenue TTM||$29.2 million|
|Gross profit TTM||$24 million|
|Return on assets TTM||-7.24%|
|Return on equity TTM||-19.95%|
|Market capitalisation||$1.2 billion|
TTM: trailing 12 months
Polynovo share dividends
We're not expecting Polynovo to pay a dividend over the next 12 months.
Have Polynovo's shares ever split?
Polynovo's shares were split on 2 May 2004. This wouldn't directly have changed the overall worth of your Polynovo shares – just the quantity. However, indirectly, the new INF% higher share price could have impacted the market appetite for Polynovo shares which in turn could have impacted Polynovo's share price.
Polynovo share price volatility
Over the last 12 months, Polynovo's shares have ranged in value from as little as $1.65 up to $4.08. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Polynovo's is 1.2245. This would suggest that Polynovo's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Polynovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing Syntrel hernia devices for hernia repair; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to Polynovo Limited in November 2014. Polynovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Stocks similar to Polynovo
Polynovo in the news
Frequently asked questions
More guides on Finder
Why is the a2 Milk (A2M) share price on a high?
Shares in the trans-Tasman dairy company are down 55% over the last 12 months.
Why has the Bank of Queensland (BOQ) share price stumbled?
Shares in the Brisbane-based lender have risen nearly 60% in the last 12 months.
Today’s ASX top stocks: Deep Yellow (DYL ↑23.1%), Paladin Energy (PDN ↑23.0%)
The 10 biggest movers on the ASX for Wednesday 13 October 2021.
How to invest in the Tissue Repair IPO
Everything we know about the Tissue Repair IPO, plus information on how to buy in.
How to buy Illuvium (ILV) in Australia
This guide will show you step-by-step instructions on how to buy the Illuvium (ILV) token as well as a list of exchanges you can trade it on.
What is weighing down the Westpac share price today?
Westpac shares are up 43% over the past 12 months.
16 stocks to watch following Sydney’s “freedom day”
Airports, travel agents and pubs are set to soar post lockdown, but should share investors look beyond immediate short-term wins?
Why is the IAG share price on a high today?
Shares in the insurer are up just 10% in the last 12 months.
How to invest in the Nimy Resources IPO
Everything we know about the Nimy Resources IPO, plus information on how to buy in.
Ask an Expert